|
MechanismZNF207 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Jiangsu Ruizhi Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Jiangsu Ruizhi Pharmaceutical Technology Co., Ltd.
100 Deals associated with Jiangsu Ruizhi Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Jiangsu Ruizhi Pharmaceutical Technology Co., Ltd.